Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment.
- DOI
- 10.1016/j.ejmech.2025.117480
- Published
- 2025-03-07
- Container
- Eur J Med Chem
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2025.117480,
title = {Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment.},
author = {Hou Y and Li S and Ren L and Zhang L and Zhang N and Miao R and Huang Q and Li Z and Hu C and Xi Z and Tong M and Gong P and Zhao Y and Liu Y and Liu J.},
year = {2025},
journal = {Eur J Med Chem},
doi = {10.1016/j.ejmech.2025.117480},
url = {https://doi.org/10.1016/j.ejmech.2025.117480}
}RIS
TY - JOUR TI - Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment. AU - Hou Y AU - Li S AU - Ren L AU - Zhang L AU - Zhang N AU - Miao R AU - Huang Q AU - Li Z AU - Hu C AU - Xi Z AU - Tong M AU - Gong P AU - Zhao Y AU - Liu Y AU - Liu J. PY - 2025 JO - Eur J Med Chem DO - 10.1016/j.ejmech.2025.117480 UR - https://doi.org/10.1016/j.ejmech.2025.117480 ER -
APA
Y, H., S, L., L, R., L, Z., N, Z., R, M., Q, H., Z, L., C, H., Z, X., M, T., P, G., Y, Z., Y, L., & J., L. (2025). Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment.. Eur J Med Chem. https://doi.org/10.1016/j.ejmech.2025.117480
Source records
- europe-pmc · retrieved 2026-09-26T12:05:26.990Z